Beta Drugs Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
1293.05 Cr.
|
P/BV
|
10.52
|
Book Value (Rs.)
|
127.82
|
52 Week High/Low (Rs.)
|
1595/660
|
FV/ML
|
10/200
|
P/E(X)
|
42.09
|
Bookclosure
|
30/09/2023
|
EPS (Rs.)
|
31.95
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 31.95 | 25.82 | 12.20 | 9.93 | 9.30 |
Diluted EPS (Rs.) | 31.95 | 25.82 | 12.20 | 9.93 | 9.30 |
Cash EPS (Rs.) | 42.78 | 33.37 | 19.34 | 13.70 | 12.58 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 127.82 | 96.05 | 71.37 | 59.41 | 47.31 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 127.82 | 96.05 | 71.37 | 59.41 | 47.31 |
Revenue From Operations / Share (Rs.) | 236.24 | 191.22 | 120.79 | 94.45 | 76.22 |
PBDIT / Share (Rs.) | 56.05 | 45.20 | 26.26 | 19.05 | 14.08 |
PBIT / Share (Rs.) | 45.22 | 37.65 | 19.11 | 15.14 | 10.80 |
PBT / Share (Rs.) | 42.70 | 35.68 | 16.59 | 12.45 | 9.14 |
Net Profit / Share (Rs.) | 31.95 | 25.82 | 12.20 | 9.79 | 9.29 |
NP After MI And SOA / Share (Rs.) | 31.95 | 25.82 | 12.20 | 9.79 | 9.29 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 23.72 | 23.63 | 21.73 | 20.17 | 18.47 |
PBIT Margin (%) | 19.14 | 19.69 | 15.81 | 16.03 | 14.16 |
PBT Margin (%) | 18.07 | 18.65 | 13.73 | 13.18 | 11.99 |
Net Profit Margin (%) | 13.52 | 13.50 | 10.09 | 10.36 | 12.19 |
NP After MI And SOA Margin (%) | 13.52 | 13.50 | 10.09 | 10.36 | 12.19 |
Return on Networth / Equity (%) | 24.99 | 26.88 | 17.08 | 16.48 | 19.64 |
Return on Capital Employeed (%) | 32.10 | 33.24 | 22.09 | 20.65 | 18.62 |
Return On Assets (%) | 15.48 | 15.72 | 9.97 | 8.78 | 9.74 |
Long Term Debt / Equity (X) | 0.05 | 0.12 | 0.16 | 0.17 | 0.17 |
Total Debt / Equity (X) | 0.13 | 0.17 | 0.21 | 0.34 | 0.44 |
Asset Turnover Ratio (%) | 1.27 | 1.09 | 0.82 | 0.79 | 1.02 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 2.03 | 1.98 | 1.99 | 1.53 | 1.40 |
Quick Ratio (X) | 1.54 | 1.52 | 1.53 | 1.19 | 1.11 |
Inventory Turnover Ratio (X) | 4.16 | 5.70 | 4.47 | 4.43 | 7.19 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 22.31 | 22.88 | 10.43 | 7.08 | 8.51 |
Interest Coverage Ratio (Post Tax) (%) | 13.72 | 14.07 | 5.85 | 4.64 | 6.62 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 599.62 | 542.92 | 119.61 | 52.99 | 105.50 |
EV / Net Operating Revenue (X) | 2.64 | 2.95 | 1.03 | 0.58 | 1.60 |
EV / EBITDA (X) | 11.13 | 12.49 | 4.74 | 2.89 | 8.66 |
MarketCap / Net Operating Revenue (X) | 2.65 | 2.96 | 0.99 | 0.42 | 1.37 |
Price / BV (X) | 4.90 | 5.89 | 1.68 | 0.67 | 2.21 |
Price / Net Operating Revenue (X) | 2.65 | 2.96 | 0.99 | 0.42 | 1.37 |
EarningsYield | 0.05 | 0.04 | 0.10 | 0.24 | 0.08 |